Latest

Does Targeted Inflammation Therapy Reduce Risk of CV Events, Lung Cancer?

Does Targeted Inflammation Therapy Reduce Risk of CV Events, Lung Cancer?

Canakinumab vs placebo showed promising results in preventing recurrent cardiovascular events and incidences of lung cancer.

Improving Anorexia-Cachexia in Non-small Cell Lung Cancer

Improving Anorexia-Cachexia in Non-small Cell Lung Cancer

Data from 5 phase 2/3 studies demonstrate improved weight and body mass in patients with NSCLC receiving anamorelin.

Improving Survival in Resected NSCLC With Adoptive Cellular Immunotherapy

Improving Survival in Resected NSCLC With Adoptive Cellular Immunotherapy

A phase 3 trial examined the efficacy of chemoimunnotherapy vs chemotherapy alone in postsurgical patients with non-small cell lung cancer.

Clinical Trial Eligibility Criteria: Barriers for People With Lung Cancer

Clinical Trial Eligibility Criteria: Barriers for People With Lung Cancer

A retrospective study of lung cancer clinical trials found that trials continue to increase their eligibility criteria, creating barriers to patient access.

FDA: Priority Review for Alectinib for ALK-positive NSCLC

FDA: Priority Review for Alectinib for ALK-positive NSCLC

Priority review for alectinib was granted based on evidence from the phase 3 ALEX and J-ALEX clinical trials.

FDA: Durvalumab Granted Breakthrough Therapy Designation for NSCLC

FDA: Durvalumab Granted Breakthrough Therapy Designation for NSCLC

Durvalumab can be used to treat patients with locally advanced, unrescetable NSCLC, who do not relapse after platinum-based chemoradiation.

Lung Cancer Screening CT Scans in High-Risk Smokers Increase Cessation Rates

Lung Cancer Screening CT Scans in High-Risk Smokers Increase Cessation Rates

Patients who underwent lung CT screening had a higher 2-week smoking cessation rate vs patients who did not undergo screening.

Pulmonary Rehabilitation Benefits in COPD, Lung Cancer, and Other Respiratory Conditions

Pulmonary Rehabilitation Benefits in COPD, Lung Cancer, and Other Respiratory Conditions

Recent research suggests that perioperative and postoperative pulmonary rehabilitation improves outcomes in patients undergoing thoracic surgery.

Alternative vs Usual Tx Outcomes for Lung, Breast, Colorectal Cancers

Alternative vs Usual Tx Outcomes for Lung, Breast, Colorectal Cancers

Patients who underwent alternative therapies were more likely to die vs those who underwent usual care.

B Vitamin Supplementation Not Associated With Decreased Cancer Risk

B Vitamin Supplementation Not Associated With Decreased Cancer Risk

Men and male smokers were most impacted by the association between vitamin B6 and B12 supplementation and lung cancer risk.

Accuracy of Physician Estimates of Pulmonary Nodule Pretest Probability of Malignancy

Accuracy of Physician Estimates of Pulmonary Nodule Pretest Probability of Malignancy

Physicians can differentiate between benign and malignant pulmonary nodules, but do not consistently follow guideline-based recommendations when selecting the next diagnostic test.

Does Palifosfamide With Platinum Doublet Prolong SCLC Survival?

Does Palifosfamide With Platinum Doublet Prolong SCLC Survival?

Palifosfamide added to carboplatin and etoposide did not prolong survival among patients with extensive-stage small-cell lung cancer.

Incident Lung Cancer Associated With Total, Saturated Fat Consumption

Incident Lung Cancer Associated With Total, Saturated Fat Consumption

Over 18,000 cases of incident lung cancer were identified over mean 9.4 years of follow-up.

ASCO Releases Updated Guidelines for Antiemetics in Cancer Patients

ASCO Releases Updated Guidelines for Antiemetics in Cancer Patients

ASCO has released updated guidelines to help physicians manage nausea and vomiting caused by antineoplastic agents in cancer patients.

Caregiver vs Patient View of Functional Status in Older Cancer Patients

Caregiver vs Patient View of Functional Status in Older Cancer Patients

Caregivers often rate patients as having poorer functional status than patients rate themselves.

Predicting Overall Survival With Neutrophil-Lymphocyte Ratio in NSCLC

Predicting Overall Survival With Neutrophil-Lymphocyte Ratio in NSCLC

Valuable information regarding patients' life expectancy can be collected through neutrophil-lymphocyte ratio biomarkers.

Child Intelligence Scores Tied to Mortality Risk for CV, Respiratory, Digestive Diseases

Child Intelligence Scores Tied to Mortality Risk for CV, Respiratory, Digestive Diseases

Childhood intelligence scores are associated with lower risk of mortality caused by coronary heart disease, cancers related to smoking, respiratory diseases, digestive diseases, injury, and dementia.

ASCO: Efficacy of Neoadjuvant Nivolumab in NSCLC

ASCO: Efficacy of Neoadjuvant Nivolumab in NSCLC

Researchers considered the response rate "encouraging" and comparable to cisplatin-based neoadjuvant therapy outcomes.

Examining the Relationship Between Neurocognitive Function and QoL in Advanced Lung Cancer

Examining the Relationship Between Neurocognitive Function and QoL in Advanced Lung Cancer

Patients with metastatic lung cancer require careful considerations concerning quality of life.

9/11 First Responders Experiencing Higher Rates of Chronic Cardiovascular, Respiratory Diseases

9/11 First Responders Experiencing Higher Rates of Chronic Cardiovascular, Respiratory Diseases

Intense exposure over the course of a single day has been linked to an elevated risk of developing chronic health conditions.

Sign Up for Free e-newsletters